Quenna PMQ
Finnrick has tested 20 samples from Quenna PMQ across 2 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 9 | 5 Oct 2025 | 23 Apr 2026 | |||||
| Tirzepatide | 11 | 16 Jul 2025 | 1 Jun 2026 | |||||
The Quenna PMQ samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Quenna PMQ tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 1 Jun 2026 | Tirzepatide | View | 40mg | 46.1mg | +15.3% | 99.90% | below LOQ | (no batch ID) | No label / Silver crimp / Red cap | Lab E | Public | |
| 23 Apr 2026 | Retatrutide | View | 10mg | ⚠️ Sample does not contain Retatrutide | n/a | QPR022526 | White Label / Silver Crimp / Green Cap | Lab E | Public | |||
| 23 Apr 2026 | Tirzepatide | View | 30mg | ⚠️ Sample does not contain Tirzepatide | n/a | Qp022525 | White Label / Silver Crimp / Yellow Cap | Lab E | Public | |||
| 29 Mar 2026 | Retatrutide | View | 40mg | 43.3mg | +8.3% | 99.90% | n/a | (no batch ID) | Silver Label / Silver Crimp / Clear Pink Cap | Lab G | Public | |
| 2 Mar 2026 | Tirzepatide | View | 40mg | 33.4mg | -16.5% | 99.90% | n/a | Jan.2,2026 | No Label / Silver Crimp / Clear Pink Cap | Lab E | Public | |
| 18 Feb 2026 | Tirzepatide | View | 10mg | 11.2mg | +12.0% | 98.68% | n/a | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 26 Jan 2026 | Tirzepatide | View | 30mg | 35.4mg | +18.0% | 99.80% | n/a | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab G | Public | |
About Quenna PMQ Test Results From Finnrick
Quenna PMQ is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 2 products and 20 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Quenna PMQ Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for Quenna PMQ, and 3 in the past three months. The overall dataset includes 20 tested samples with an average score of 6.1/10 across all products.
Across 20 identity-tested samples, 90% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 94% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 2):
- Tirzepatide (11 tests, 91% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 2.0 to 9.0 (average 6.0/10), suggesting significant batch-to-batch differences.
- Retatrutide (9 tests, 89% identity pass, median purity 99.7%) — Test scores are highly variable, ranging from 2.0 to 9.7 (average 6.4/10), suggesting significant batch-to-batch differences.